Европейский союз - эстонский - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - kartsinoom, squamous cell - antineoplastilised ained - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Эстония - эстонский - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 25mg 110tk; 25mg 28tk; 25mg 56tk; 25mg 30tk; 25mg 100tk; 25mg 90tk; 25mg 70tk; 25mg 98tk; 25mg 84tk

Эстония - эстонский - Ravimiamet

krka d.d. novo mesto - mirtasapiin - suus dispergeeruv tablett - 15mg 70tk; 15mg 30tk; 15mg 96tk; 15mg 28tk; 15mg 14tk; 15mg 12tk; 15mg 18tk; 15mg 48tk; 15mg 6tk; 15mg 180tk; 15mg 20tk; 15mg 60tk; 15mg 90tk; 15mg 50tk

Эстония - эстонский - Ravimiamet

krka d.d. novo mesto - asitromütsiin - suukaudse suspensiooni pulber - 40mg 1ml 15ml 1tk; 40mg 1ml 30ml 1tk; 40mg 1ml 37.5ml 1tk; 40mg 1ml 22.5ml 1tk

Эстония - эстонский - Ravimiamet

krka d.d. novo mesto - mirtasapiin - suus dispergeeruv tablett - 45mg 96tk; 45mg 28tk; 45mg 180tk; 45mg 90tk; 45mg 10tk; 45mg 48tk; 45mg 50tk; 45mg 60tk; 45mg 56tk; 45mg 14tk; 45mg 12tk; 45mg 30tk; 45mg 100tk

Эстония - эстонский - Ravimiamet

accord healthcare b.v. - gemtsitabiin - infusioonilahuse kontsentraat - 100mg 1ml 10ml 1tk; 100mg 1ml 15ml 1tk; 100mg 1ml 20ml 1tk

Эстония - эстонский - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 50mg 30tk

Эстония - эстонский - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 12,5mg 30tk

Эстония - эстонский - Ravimiamet

krka, d.d., novo mesto - mirtasapiin - õhukese polümeerikattega tablett - 45mg 50tk; 45mg 14tk; 45mg 90tk; 45mg 500tk; 45mg 250tk; 45mg 200tk; 45mg 48tk; 45mg 28tk

Эстония - эстонский - Ravimiamet

krka, d.d., novo mesto - mirtasapiin - õhukese polümeerikattega tablett - 15mg 500tk; 15mg 20tk; 15mg 300tk; 15mg 6tk; 15mg 60tk; 15mg 14tk; 15mg 50tk; 15mg 250tk; 15mg 200tk; 15mg 90tk; 15mg 56tk; 15mg 70tk; 15mg 30tk; 15mg 28tk